Key facts
- Kitt medical’s last known valuation is $2.3M (Oct 2022).
- It has raised $640K; the latest was Angel (individual) in Feb 2025.
- Notable investors include Deborah Meaden, Loughborough University, Steven Bartlett, Vantage (United Kingdom).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Kitt medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Kitt medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kitt medical
Provider of defibrillator-like medical kit intended to provide emergency allergy medication and training to schools and qualifying businesses. The company offers kits for emergency anaphylaxis treatment medication and medical training for staff and incident reporting tools with an annual subscription service, enabling clients to get help for those suffering from allergies.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 10
- Website
- kittmedical.com/
- Ownership
- Privately Held (backing)
Kitt medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kitt medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kitt medical in its N-PORT filings yet. We sweep new filings monthly.